Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability

Stroke

Volumn 39, Issue 11, 2008, Pages 3092-3095

  Handberg, Aase ^a   Skjelland, Mona ^b   Michelsen, Annika E ^b   Sagen, Ellen Lund ^b   Krohg Sørensen, Kirsten ^b   Russell, David ^b   Dahl, Arve ^b   Ueland, Thor ^b   Øie, Erik ^b   Aukrust, Pål ^b   Halvorsen, Bente ^b,c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Atherosclerosis; Carotid artery disease; Inflammation; Lipids; Stroke

Indexed keywords

BETA THROMBOGLOBULIN; C REACTIVE PROTEIN; CD36 ANTIGEN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIAC PATIENT; CAROTID ARTERY OBSTRUCTION; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTERNAL CAROTID ARTERY; INTIMA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PRIORITY JOURNAL; BLOOD; CAROTID ARTERY DISEASE; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; ANTIGENS, CD36; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; CAROTID STENOSIS; HUMANS; MALE; MIDDLE AGED;

EID: 55749104215     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.517128     Document Type: Article

References (14)

1. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83:456S-460S.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
3. Nakagawa-Toyama Y, Yamashita S, Miyagawa J, Nishida M, Nozaki S, Nagaretani H, Sakai N, Hiraoka H, Yamamori K, Yamane T, Hirano K, Matsuzawa Y. Localization of CD36 and scavenger receptor class a in human coronary arteries - a possible difference in the contribution of both receptors to plaque formation. Atherosclerosis. 2001;156:297-305.
4. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL. Targeted disruption of the class b scavenger receptor cd36 protects against atherosclerotic lesion development in mice. J Clin Invest. 2000;105:1049-1056.
5. Handberg A, Levin K, Højlund K, Beck-Nielsen H. Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance. Circulation. 2006;114:1169 -1176.
6. Skjelland M, Michelsen AE, Krohg-Sørensen K, Tennøe B, Dahl A, Bakke S, Brosstad F, Damås JK, Russell D, Halvorsen B, Aukrust P. Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity. Atherosclerosis. 2007; 195:142-146.
7. Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Frøland SS, Krohg-Sorensen K, Russell D, Aukrust P, Halvorsen B. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation. 2007;115:972-980.
8. Collot-Teixeira S, Martin J, McDermott-Roe C, Poston R, McGregor JL. CD36 and macrophages in atherosclerosis. Cardiovasc Res. 2007;75: 468-477.
9. Tuomisto TT, Riekkinen MS, Viita H, Levonen AL, Yla-Herttuala S. Analysis of gene and protein expression during monocyte-macrophage differentiation and cholesterol loading-cDNA and protein array study. Atherosclerosis. 2005;180:283-291.
10. Nakata A, Nakagawa Y, Nishida M, Nozaki S, Miyagawa J, Nakagawa T, Tamura R, Matsumoto K, Kameda-Takemura K, Yamashita S, Matsuzawa Y. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. Arterioscler Thromb Vasc Biol. 1999;19:1333-1339.
11. Littlewood TD, Bennett MR. Apoptotic cell death in atherosclerosis. Curr Opin Lipidol. 2003;14:469-475.
12. Adachi H, Tsujimoto M. Endothelial scavenger receptors. Prog Lipid Res. 2006;45:379-404.
13. Podrez EA, Byzova TV, Febbraio M, Salomon RG, Ma Y, Valiyaveettil M, Poliakov E, Sun M, Finton PJ, Curtis BR, Chen J, Zhang R, Silverstein RL, Hazen SL. Platelet CD36 links hyperlip-idemia, oxidant stress and a prothrombotic phenotype. Nat Med. 2007; 13:1086-1095.
14. Horstmann S, Kalb P, Koziol J, Gardner H, Wagner S. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke. 2003;34:2165-2170.